GSA Capital Partners »

Fate Therapeutics shares owned by GSA Capital Partners

Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in Fate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fate Therapeutics held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fate Therapeutics by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $384k 52k 7.35
2023-12-31 $161k 43k 3.74
2023-09-30 $537k 253k 2.12
2023-06-30 $925k 194k 4.76
2023-03-31 $1.2M 210k 5.70
2022-12-31 $590k 58k 10.10